()-Carnitine does not increase glucose and urea production from L-glutamine, but stimulates propionate gluconeogenesis in rat renal cortical slices, and significantly reduces hepatic ketone body levels in rats fed a diet containing 30% high fat plus 20% 1,3-butanediol
We ask whether a cognitive-computational index of motivationreliably linked to neuropsychiatric symptomsis altered in the context of type-2 diabetes and treatment with a GLP-1 agonist (semaglutide)
From a metabolic perspective, fasting periods can influence blood glucose regulation in several ways
Inflammatory bowel disease (IBD) patients, including those with Crohn's disease or ulcerative colitis, require careful evaluation before GLP-1 use
There is growing buzz around a new approach to GLP-1 coverage: removing GLP-1 coverage from the traditional pharmacy benefit manager (PBM) reimbursement model and instead reimbursing employees for GLP-1s through a direct-to-consumer or carve-out model tied to a utilization management program
GLP-1 medications like semaglutide and tirzepatide can help by reducing appetite and making a lower-calorie diet easier to maintain
